Piramal Healthcare Limited (PHL) (erstwhile Nicholas Piramal India) is a Mumbai-based pharmaceutical company incorporated as Indian Schering Limited in 26th April of the year 1947 under British Schering Ltd.
It operates in the therapeutic segments of anti-bacterials cardiovasculars anti-diabetics nutritional central nervous system and gastro-intestinal. In addition it has a presence in the OTC segment through various joint ventures and alliances. The Company’s manufacturing activities are well supported by active research and development the R&D facility called the Quest Institute of Life Sciences in Mumbai that focuses on process development.The name of the company was changed from Indian Schering Ltd to Nicholas Laboratories India Ltd with effect from 27th September of the year 1979.
The Pharmaceutical division of the company introduced a medicine called `Mono Sorbitrate’ in the year 1988 for cardiac patients. With effect from 1st April of the year 1990 Gujarat Glass Ltd (GGL) was merged with the company. During the year 1991 the new formulation plant at Pithampur in Madhya Pradesh was commissioned. After a year in 1992 the company had set-up a second formulation plant at Pithampur in Madhya Pradesh with the State-of-the-art manufacturing facilities. With effect from 2nd December of the year 1992 the name of the company was changed from `Nicholas Laboratories Ltd’ to `Nicholas Piramal India Ltd.’ PHL entered into a joint venture (JV) agreement with the leading manufacturers of ophthalmic products Allergan of U.S.A in the year 1993 and also the company made a JV agreement with Sateliec France in the year 1994 for dental care products. During the year 1995 PHL had entered into a scheme of arrangement with Sumitra Pharmaceutical and Chemicals Ltd (SPCL) Hyderabad. Under the scheme bulk drug division of SPCL transferred and vested in the company effective from April of the same year.
The Company entered into a product tie-up with F.Hoffman-La-Roche and Boehringer Mannheim in the year 1996 both leads in Pharma research. The Flaconnage (Glass) Division of the company was successfully commissioned 5MW captive power plant at Kosamba in the same year 1996 to insulate the division from the vagaries of power availability and tariff increases. With effect from 1st April of the identical year of 1996 Boehringer Mannheim India Ltd. (BMIL) was merged with company. During the year 1997 PHL’s state-of-the-art 230 TPD plant for manufacture of sodaline containers at Jambusar near Baroda was commissioned with an investment of Rs 125 crores and also in the same year the company made various agreements regarding marketing and in different disciplines….Read More
1 comment:
Tata Indica Vista Spare Parts
Post a Comment